Catalyst Pharmaceuticals, Inc. - Common Stock (NQ:CPRX)
Price and Volume
Detailed Quote| Volume | 263,576 |
| Open | 24.53 |
| Bid (Size) | 24.17 (600) |
| Ask (Size) | 24.19 (200) |
| Prev. Close | 24.45 |
| Today's Range | 24.10 - 24.60 |
| 52wk Range | 19.05 - 26.58 |
| Shares Outstanding | 102,780,151 |
| Dividend Yield | N/A |
Top News
More NewsPerformance
More News
Read More
2 Under-the-Radar Biotech Stocks Set to Boom in 2026 ↗
January 24, 2026
Earnings Scheduled For November 5, 2025 ↗
November 05, 2025
What Does the Market Think About Catalyst Pharmaceuticals Inc? ↗
October 21, 2025
Frequently Asked Questions
Is Catalyst Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Catalyst Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Catalyst Pharmaceuticals, Inc. - Common Stock trade on?
Catalyst Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Catalyst Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Catalyst Pharmaceuticals, Inc. - Common Stock is CPRX on the Nasdaq Stock Market
What is the current price of Catalyst Pharmaceuticals, Inc. - Common Stock?
The current price of Catalyst Pharmaceuticals, Inc. - Common Stock is 24.18
When was Catalyst Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Catalyst Pharmaceuticals, Inc. - Common Stock was at 02/10/26 02:01 PM ET
What is the market capitalization of Catalyst Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Catalyst Pharmaceuticals, Inc. - Common Stock is 2.49B
How many shares of Catalyst Pharmaceuticals, Inc. - Common Stock are outstanding?
Catalyst Pharmaceuticals, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.